Story perspectives
Taiwan and JCR Lead Asia's Gene Therapy Innovations
10/2/2025
31 4
1 of 1
Story summary
- Taiwan Cell Manufacturing Company (tcmc) will showcase CDMO services for cell and gene therapy at BioJapan 2025, aiming to become Asia's hub for CAR-T.
- JCR Pharmaceuticals will present data on its JUST-AAV gene therapy platform at the ESGCT Congress, highlighting targeted delivery and modified adeno-associated virus (AAV) vectors.
- Both emphasize collaboration and innovation to advance therapies in Asia and globally.
